logo
logo

Lumos Diagnostics Raises AU$25m in Oversubscribed Pre-IPO Capital Raise

Lumos Diagnostics Raises AU$25m in Oversubscribed Pre-IPO Capital Raise

10/06/20, 9:59 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgmelbourne
Money raised
$25 million
Lumos Diagnostics, a rapid point-of-care diagnostics company, has closed an oversubscribed AU$25 million pre-IPO capital raise, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing.

Company Info

Company
Lumos Diagnostics
Location
melbourne, florida, united states
Additional Info
Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases with unmet diagnostic needs.